AU5274000A - Prevention of regression in refractive keratoplasty - Google Patents
Prevention of regression in refractive keratoplastyInfo
- Publication number
- AU5274000A AU5274000A AU52740/00A AU5274000A AU5274000A AU 5274000 A AU5274000 A AU 5274000A AU 52740/00 A AU52740/00 A AU 52740/00A AU 5274000 A AU5274000 A AU 5274000A AU 5274000 A AU5274000 A AU 5274000A
- Authority
- AU
- Australia
- Prior art keywords
- regression
- prevention
- refractive keratoplasty
- keratoplasty
- refractive
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A61K9/0051—Ocular inserts, ocular implants
Landscapes
- Health & Medical Sciences (AREA)
- Ophthalmology & Optometry (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (15)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13745999P | 1999-06-04 | 1999-06-04 | |
US60137459 | 1999-06-04 | ||
US14506999P | 1999-07-20 | 1999-07-20 | |
US60145069 | 1999-07-20 | ||
US14712399P | 1999-08-04 | 1999-08-04 | |
US60147123 | 1999-08-04 | ||
US15277399P | 1999-09-03 | 1999-09-03 | |
US60152773 | 1999-09-03 | ||
US15358999P | 1999-09-13 | 1999-09-13 | |
US60153589 | 1999-09-13 | ||
US16114799P | 1999-10-22 | 1999-10-22 | |
US60161147 | 1999-10-22 | ||
US55057900A | 2000-04-17 | 2000-04-17 | |
US09550579 | 2000-04-17 | ||
PCT/US2000/013600 WO2000074648A2 (en) | 1999-06-04 | 2000-05-15 | Prevention of regression in refractive keratoplasty |
Publications (1)
Publication Number | Publication Date |
---|---|
AU5274000A true AU5274000A (en) | 2000-12-28 |
Family
ID=27568914
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU52740/00A Abandoned AU5274000A (en) | 1999-06-04 | 2000-05-15 | Prevention of regression in refractive keratoplasty |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU5274000A (en) |
WO (1) | WO2000074648A2 (en) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006082588A2 (en) * | 2005-02-07 | 2006-08-10 | Pharmalight Inc. | Method and device for ophthalmic administration of active pharmaceutical ingredients |
US8992516B2 (en) | 2007-07-19 | 2015-03-31 | Avedro, Inc. | Eye therapy system |
US8202272B2 (en) | 2007-07-19 | 2012-06-19 | Avedro, Inc. | Eye therapy system |
EP2227197A4 (en) | 2007-12-05 | 2011-06-22 | Avedro Inc | Eye therapy system |
US8348935B2 (en) | 2008-01-23 | 2013-01-08 | Avedro, Inc. | System and method for reshaping an eye feature |
US8409189B2 (en) | 2008-01-23 | 2013-04-02 | Avedro, Inc. | System and method for reshaping an eye feature |
US8469952B2 (en) | 2008-01-23 | 2013-06-25 | Avedro, Inc. | System and method for positioning an eye therapy device |
US8398628B2 (en) | 2008-09-19 | 2013-03-19 | Avedro, Inc. | Eye therapy system |
WO2010039854A1 (en) | 2008-09-30 | 2010-04-08 | Neal Marshall | Eye therapy system |
EP2346429A4 (en) | 2008-10-01 | 2012-10-24 | Avedro Inc | Eye therapy system |
JP2012508087A (en) | 2008-11-11 | 2012-04-05 | アヴェドロ・インコーポレーテッド | Eye treatment system |
WO2010115121A1 (en) | 2009-04-02 | 2010-10-07 | Avedro, Inc. | Eye therapy system |
WO2011050164A1 (en) | 2009-10-21 | 2011-04-28 | Avedro, Inc. | Eye therapy |
US8177778B2 (en) | 2009-10-30 | 2012-05-15 | Avedro, Inc. | System and method for stabilizing corneal tissue after treatment |
JP6377906B2 (en) | 2010-03-19 | 2018-08-22 | アヴェドロ・インコーポレーテッドAvedro,Inc. | System for applying and monitoring eye treatment |
US20120289886A1 (en) * | 2010-04-13 | 2012-11-15 | Avedro, Inc. | Controlled application of cross-linking agent |
WO2012162529A1 (en) | 2011-05-24 | 2012-11-29 | Avedro, Inc. | Systems and methods for reshaping an eye feature |
JP6122845B2 (en) | 2011-06-02 | 2017-04-26 | アヴェドロ・インコーポレーテッドAvedro,Inc. | System and method for monitoring the delivery of time-based photoactive agents or the presence of photoactive markers |
EP4074294A1 (en) | 2012-07-16 | 2022-10-19 | Avedro, Inc. | Systems and methods for corneal cross-linking with pulsed light |
US9498114B2 (en) | 2013-06-18 | 2016-11-22 | Avedro, Inc. | Systems and methods for determining biomechanical properties of the eye for applying treatment |
WO2014205145A1 (en) | 2013-06-18 | 2014-12-24 | Avedro, Inc. | Systems and methods for determining biomechanical properties of the eye for applying treatment |
JP6644799B2 (en) | 2014-10-27 | 2020-02-12 | アヴェドロ・インコーポレーテッドAvedro,Inc. | System and method for ocular crosslinking treatment |
WO2016077747A1 (en) | 2014-11-13 | 2016-05-19 | Avedro, Inc. | Multipass virtually imaged phased array etalon |
EP3285704B1 (en) | 2015-04-24 | 2020-11-18 | Avedro Inc. | Systems for photoactivating a photosensitizer applied to an eye |
WO2016191342A1 (en) | 2015-05-22 | 2016-12-01 | Avedro, Inc. | Systems and methods for monitoring cross-linking activity for corneal treatments |
CN108025011A (en) | 2015-07-21 | 2018-05-11 | 艾维德洛公司 | With the system and method for photosensitizing agents eyes |
KR20180074674A (en) | 2015-10-23 | 2018-07-03 | 더 트러스티스 오브 컬럼비아 유니버시티 인 더 시티 오브 뉴욕 | Intra-tissue laser-induced collagen crosslinking |
US11497403B2 (en) | 2016-06-10 | 2022-11-15 | The Trustees Of Columbia University In The City Of New York | Devices, methods, and systems for detection of collagen tissue features |
US11666481B1 (en) | 2017-12-01 | 2023-06-06 | The Trustees Of Columbia University In The City Of New York | Diagnosis and treatment of collagen-containing tissues |
US11766356B2 (en) | 2018-03-08 | 2023-09-26 | Avedro, Inc. | Micro-devices for treatment of an eye |
JP2022544110A (en) | 2019-08-06 | 2022-10-17 | アヴェドロ・インコーポレーテッド | Photoactivated system and method for corneal cross-linking treatment |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5114627A (en) | 1986-10-16 | 1992-05-19 | Cbs Lens | Method for producing a collagen hydrogel |
US5360611A (en) * | 1988-10-03 | 1994-11-01 | Alcon Laboratories, Inc. | Pharmaceutical compositions and methods of treatment of the cornea following ultraviolet laser irradiation |
US5270051A (en) | 1991-10-15 | 1993-12-14 | Harris Donald H | Enzyme-orthokeratology |
US6013628A (en) | 1994-02-28 | 2000-01-11 | Regents Of The University Of Minnesota | Method for treating conditions of the eye using polypeptides |
AU6764396A (en) | 1995-08-08 | 1997-03-05 | Thomas Jefferson University | Recombinant c-proteinase and processes, methods and uses thereof |
US6033396A (en) | 1995-11-06 | 2000-03-07 | Huang; David | Apparatus and method for performing laser thermal keratoplasty with minimized regression |
JP2000511423A (en) | 1996-05-30 | 2000-09-05 | ウィスコンシン アラムニ リサーチ ファンデーション | Mammalian toroid-like genes and proteins |
US5811446A (en) | 1997-04-18 | 1998-09-22 | Cytos Pharmaceuticals Llc | Prophylactic and therapeutic methods for ocular degenerative diseases and inflammations and histidine compositions therefor |
US6037139A (en) | 1997-06-03 | 2000-03-14 | Wisconsin Alumni Research Foundation | System for assaying modulators of procollagen maturation |
-
2000
- 2000-05-15 WO PCT/US2000/013600 patent/WO2000074648A2/en active Application Filing
- 2000-05-15 AU AU52740/00A patent/AU5274000A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2000074648A3 (en) | 2001-02-01 |
WO2000074648A2 (en) | 2000-12-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU5274000A (en) | Prevention of regression in refractive keratoplasty | |
AU1731101A (en) | Ophthalmic compositions | |
AU3728800A (en) | Multi-purpose eyewear | |
AU3731600A (en) | Composition and structures made therefrom | |
AU2001267851A1 (en) | Oxygen-containing ophthalmic composition | |
AU6820000A (en) | Novel proteases and variants thereof | |
AU5727200A (en) | Super vision | |
AUPQ419099A0 (en) | Novel compositions and methods | |
AU4819300A (en) | Methods of refractive correction of the eye | |
AU1932801A (en) | Foldable eyewear | |
AU2447101A (en) | Judging changes in images of the eye | |
AU7533500A (en) | Tessellation set | |
AU5634300A (en) | Composition and films thereof | |
AU1812001A (en) | Cotton transcription factors and their uses | |
AU4431000A (en) | Novel use | |
AU4340700A (en) | Methods and compositions for use in the treatment of hyperlipidemia | |
AU4923200A (en) | Isothiazolecarboxamides and their use as microbicides | |
AU1403501A (en) | Novel composition and use | |
AU4354600A (en) | Cleaning compositions and tablets | |
AU5495101A (en) | Ophthalmic injector | |
AU3175900A (en) | Tampon | |
AU2841801A (en) | Triazolotriazinones and the use thereof | |
AU4309700A (en) | Spectacles | |
AU1554301A (en) | Radioprotecting agent | |
AU3328600A (en) | Ocular tension-lowering agents |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |